| LncRNA ZNF667-AS1 Targets miR-523-3p/KIF5C Axis to Hinder Colon Cancer Progression. | LncRNA ZNF667-AS1 Targets miR-523-3p/KIF5C Axis to Hinder Colon Cancer Progression.
Tong D, Fan L. | 06/17/2024 |
| LncRNA MORT Overexpression Inhibits Cancer Cell Migration and Invasion in Hepatocellular Carcinoma by Downregulating NOTCH1. | LncRNA MORT Overexpression Inhibits Cancer Cell Migration and Invasion in Hepatocellular Carcinoma by Downregulating NOTCH1.
Lu X, Ge G, Ji F, Wang J. | 09/24/2022 |
| Regulation of IncRNA ZNF667-AS1 in Proliferation and Invasion of Esophageal Squamous Cell Carcinoma Cells via Mediating ceRNA Network. | Regulation of IncRNA ZNF667-AS1 in Proliferation and Invasion of Esophageal Squamous Cell Carcinoma Cells via Mediating ceRNA Network.
Wei L, Gu W, Hu L, Wang K, Huang H, Shen Y. | 08/27/2022 |
| LncRNA ZNF667-AS1 alleviates rheumatoid arthritis by sponging miR-523-3p and inactivating the JAK/STAT signalling pathway. | LncRNA ZNF667-AS1 alleviates rheumatoid arthritis by sponging miR-523-3p and inactivating the JAK/STAT signalling pathway.
Zhuo Q, Wei L, Yin X, Li H, Qin G, Li S, Peng TT, Liu B, Zhao S, Ye Z. | 04/2/2022 |
| LncRNA MORT negatively regulates FGF1 to suppress malignant progression of breast cancer. | LncRNA MORT negatively regulates FGF1 to suppress malignant progression of breast cancer.
Yang Q, Yang D, Zhu HB, Li P, Wu XP, Tan YR. | 03/26/2022 |
| Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect. | Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect.
Burdennyy AM, Filippova EA, Ivanova NA, Lukina SS, Pronina IV, Loginov VI, Fridman MV, Kazubskaya TP, Utkin DO, Braga EA, Kushlinskii NE. | 01/8/2022 |
| lncRNA ZNF667-AS1 (NR_036521.1) inhibits the progression of colorectal cancer via regulating ANK2/JAK2 expression. | lncRNA ZNF667-AS1 (NR_036521.1) inhibits the progression of colorectal cancer via regulating ANK2/JAK2 expression.
Zhuang L, Ding W, Ding W, Zhang Q, Xu X, Xi D. | 09/18/2021 |
| Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients. | Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients.
Yuan Q, Gao C, Lai XD, Chen LY, Lai TB., Free PMC Article | 08/28/2021 |
| ZNF667-AS1, a positively regulating MEGF10, inhibits the progression of uveal melanoma by modulating cellular aggressiveness. | ZNF667-AS1, a positively regulating MEGF10, inhibits the progression of uveal melanoma by modulating cellular aggressiveness.
Yang H, Cai MY, Rong H, Ma LR, Xu YL. | 07/31/2021 |
| IncRNA ZNF667-AS1 Suppresses Epithelial Mesenchymal Transformation by Targeting TGF-beta1 in Oral Squamous Cell Carcinoma. | IncRNA ZNF667-AS1 Suppresses Epithelial Mesenchymal Transformation by Targeting TGF-β1 in Oral Squamous Cell Carcinoma.
Zhao J, Cui Z, Dong Z, Niu Y, Yang K, Han H. | 07/17/2021 |
| LncRNAMORT is upregulated in myocardial infarction and promotes the apoptosis of cardiomyocyte by downregulating miR-93. | LncRNAMORT is upregulated in myocardial infarction and promotes the apoptosis of cardiomyocyte by downregulating miR-93.
Lv J, Zhu Y, Yao S., Free PMC Article | 12/5/2020 |
| Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma. | Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma.
Dong Z, Li S, Wu X, Niu Y, Liang X, Yang L, Guo Y, Shen S, Liang J, Guo W., Free PMC Article | 09/12/2020 |
| These key findings demonstrated that upregulation of ZNF667-AS1 could suppress the progression of cervical cancer via the modulation of miR-93-3p-dependent PEG3. | Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation.
Li YJ, Yang Z, Wang YY, Wang Y., Free PMC Article | 06/20/2020 |
| ZNF667-AS1 inhibited the proliferation of cervical cancer cells and was expected to be the biomarker and potential therapeutic target for predicting cervical cancer and determining its prognosis. | Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
Zhao LP, Li RH, Han DM, Zhang XQ, Nian GX, Wu MX, Feng Y, Zhang L, Sun ZG. | 08/18/2018 |
| Data revealed deregulation of MORT expression due to DNA hypermethylation in 15 out of the 17 most common human cancers. | A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers.
Vrba L, Garbe JC, Stampfer MR, Futscher BW, Vrba L, Garbe JC, Stampfer MR, Futscher BW., Free PMC Articles: PMC4844203, PMC4844203 | 10/22/2016 |
| The epigenetic silencing of MORT (ZNF667-AS1) in a large majority of the common human cancers suggests a potential fundamental role in cellular immortalization during human carcinogenesis. | A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers.
Vrba L, Garbe JC, Stampfer MR, Futscher BW, Vrba L, Garbe JC, Stampfer MR, Futscher BW., Free PMC Articles: PMC4844203, PMC4844203 | 05/24/2016 |